These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 22309435)

  • 21. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Allergen-specific immunotherapy or desensitization].
    Demoly P; Michel FB
    Bull Acad Natl Med; 2009 May; 193(5):1127-44; discussion 1144-5. PubMed ID: 20120392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on the position paper of the European Academy of Allergy and Clinical Immunology on allergen immunotherapy.
    Scadding GK
    Rhinology; 1999 Sep; 37(3):139-40. PubMed ID: 10567996
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel administration routes for allergen-specific immunotherapy: a review of intralymphatic and epicutaneous allergen-specific immunotherapy.
    von Moos S; Kündig TM; Senti G
    Immunol Allergy Clin North Am; 2011 May; 31(2):391-406, xi. PubMed ID: 21530827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allergen immunotherapy.
    Huggins JL; Looney RJ
    Am Fam Physician; 2004 Aug; 70(4):689-96. PubMed ID: 15338781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of standardized extracts in allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allergen immunotherapy in historical perspective.
    Cohen SG; Richard E
    Clin Allergy Immunol; 2008; 21():1-29. PubMed ID: 18828495
    [No Abstract]   [Full Text] [Related]  

  • 31. Historical perspectives of allergy and immunology and allergen immunotherapy.
    Lockey RF
    Ann Allergy Asthma Immunol; 2014 Dec; 113(6):587-92. PubMed ID: 25454016
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunotherapy coming of age: notable advances during the first hundred years.
    Nelson HS
    Expert Rev Clin Immunol; 2017 May; 13(5):389-392. PubMed ID: 28443797
    [No Abstract]   [Full Text] [Related]  

  • 33. Novel ways for immune intervention in immunotherapy: mucosal allergy vaccines.
    Mascarell L; Van Overtvelt L; Moingeon P
    Immunol Allergy Clin North Am; 2006 May; 26(2):283-306, vii-viii. PubMed ID: 16701145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One hundred and ten years of Allergen Immunotherapy: A journey from empiric observation to evidence.
    Pfaar O; Bousquet J; Durham SR; Kleine-Tebbe J; Larché M; Roberts G; Shamji MH; Gerth van Wijk R
    Allergy; 2022 Feb; 77(2):454-468. PubMed ID: 34315190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Allergen specific immunotherapy: review of new perspectives].
    Gaillard J; Bart PA; Leimgruber A; Spertini F
    Rev Med Suisse; 2011 Apr; 7(291):850-5. PubMed ID: 21598725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allergen immunotherapy: a new semantic framework from the European Academy of Allergy and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL consensus report.
    Calderón MA; Casale T; Cox L; Akdis CA; Burks AW; Nelson HS; Jutel M; Demoly P
    Allergy; 2013 Jul; 68(7):825-8. PubMed ID: 24010140
    [No Abstract]   [Full Text] [Related]  

  • 37. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Issues in stinging insect allergy immunotherapy: a review.
    Finegold I
    Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):343-7. PubMed ID: 18596592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy: The meta-analyses. What have we Learned?
    Calderón MA; Boyle RJ; Penagos M; Sheikh A
    Immunol Allergy Clin North Am; 2011 May; 31(2):159-73, vii. PubMed ID: 21530812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunotherapy concepts under investigation.
    Kündig TM
    Allergy; 2011 Jul; 66 Suppl 95():60-2. PubMed ID: 21668859
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.